(Alliance News) - Beximco Pharmaceuticals Ltd on Tuesday said it had issued a petition against nine appointments to its board by the Bangladesh Securities and Exchange Commission. Read More
(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said the Bangladesh court has referred the company's appeal in its recent fraud case to a full-court hearing, which will take place on October 28. Read More
Beximco Pharmaceuticals - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Confirms that Vice-Chair Salman Rahman was arrested by Dhaka police on Tuesday and will be held for 10 days while an investigation into alleged offences is carried out. Rahman was a private industry and investment advisor to deposed Bangladesh prime minister Sheikh Hasina, who fled the country earlier this month amid accusations of human rights abuses. Read More
Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. "The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days," Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn't expect the disruption to have a "material impact" on annual results. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Beximco Pharmaceuticals Ltd - generic pharmaceutical products and active ingredients' manufacturer - Announces that Non-Executive Director Iqbal Ahmed has been appointed as Beximco's managing director for five years with immediate effect. This appointment is subject to approval of the shareholders, and follows the departure of Nazmul Hassan. According to Beximco, Ahmed is a "long-standing member of the Beximco Pharma Board" and has over 47 years business experience, including within the pharmaceutical sector. Read More
(Alliance News) - Beximco Pharmaceuticals Ltd on Tuesday said it aimed to continue momentum into the second half as it reported profit and revenue growth for the first financial half. Read More
Beximco Pharmaceuticals Ltd - generic pharmaceutical products and active ingredients' manufacturer - Says Managing Director Nazmul Hassan will step down, effective immediately, after 14 years at the company. This follows an invitation from the Bangladeshi Prime Minister Sheikh Hasina for Hassan to join her newly formed cabinet as a minister, following the recent Bangladesh parliamentary election on Sunday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said revenue increased in its latest year, but noted that rising costs and the lack of vaccine distribution income caused profit to fall. Read More
Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active pharmaceutical ingredients maker - Clarifies recent press report that discussed findings from a planned good manufacturing procedure inspection of the company's ophthalmic manufacturing unit between July 28 and August 1 by The Malta Medicines Authority. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active pharmaceutical ingredients maker - In the financial year that ended June 30, books pretax profit of BDT6.69 billion, around GBP57.6 million, up 4.9% from BDT6.37 billion a year before. Annual revenue climbs 18% to BDT34.67 billion from BDT29.49 billion, with domestic sales rising by 21% and export sales by 14%. Declares BDT3.5 per share dividend. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More